The primary endpoint of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer
Age 18-80 years
ECOG PS ≤ 2 or KPS ≥ 70%
Patients diagnosed with endometrial cancer (endometrioid, serous cell, clear cell, carcinosarcoma) FIGO stage IB-IIIC1 candidate to post-operative external beam radiotherapy, based on molecular and histological findings
Indications for chemotherapy and/or brachytherapy are not
Written Informed Consent
Prior pelvic radiotherapy
Para-aortic lymph nodes involvement
ECOG PS ≥ 3
ARNAS Civico Di Cristina Benfratelli Hospital
Lead sponsor
Accuray Incorporated
Collaborator